SCHEMBL24414033

SCHEMBL24414033

O=C(Oc1ccc(Oc2cc(I)c(O)c(I)c2)cc1)C(F)(F)S(=O)(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 7/20 0.44
PPARG P37231 4/20 0.36
THRB P10828 4/20 0.36
THRA P10827 3/20 0.36
RXRA P19793 2/20 0.36
ITGB3 P05106 1/20 0.36
ITGAV P06756 1/20 0.36
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
NR1I2 O75469 2/20 0.33
AGTR2 P50052 1/20 0.33
BLM P54132 1/20 0.33
TLR8 Q9NR97 1/20 0.33
LMNA P02545 2/20 0.33
TTR P02766 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
PDE4D Q08499 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NR3C1 P04150 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24413648 0.95 ELANE (0.40) ELANEPPARGTHRBTHRARXRA
SCHEMBL27263117 0.89 THRB (0.35) ELANEPPARGTHRBTHRARXRA
SCHEMBL24413654 0.88 THRB (0.41) ELANEPPARGTHRBTHRARXRA
SCHEMBL24413533 0.84 ELANE (0.46) ELANEMEN1KMT2ATBXA2RALDH1A1
SCHEMBL24413508 0.84 ELANE (0.41) ELANETLR8PTPN1
SCHEMBL24413785 0.83 ELANE (0.39) ELANETLR8TBXA2RALDH1A1PTPN1
SCHEMBL24414011 0.83 ELANE (0.41) ELANETLR8LMNAALDH1A1PTPN1
SCHEMBL24413720 0.81 PCNA (0.39) ELANEPPARGTHRBTHRARXRA
SCHEMBL24413539 0.81 ELANE (0.35) ELANETHRBPCNA
SCHEMBL24413638 0.80 ELANE (0.40) ELANETLR8NR3C1CYP2C9TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, FGFR1, NHERF1 ELANE 1517/4885PPARG 108/4885THRB 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.